Solugen and ADM formed a strategic partnership to scale a range of plant-based specialty chemicals and bio-based building block molecules in a new manufacturing facility in Marshall, MN. Solugen will build a new 500,000-ft2 biomanufacturing facility adjacent to ADM’s existing corn complex in Marshall. The facility will utilize ADM-provided dextrose to scale its current line of lower-carbon organic acids and develop new molecules to replace existing fossil fuel-based materials.

The companies also plan to collaborate on commercialization opportunities of these biomaterials for a range of applications including energy, water treatment, agriculture, construction materials, cleaning, and personal care.

“The strategic partnership with ADM will allow Solugen to bring our ‘chemienzymatic’ process to a commercial scale and meet existing customer demand for our high-performance, cost-competitive, sustainable products,” said Gaurab Chakrabarti, co-founder and CEO of Solugen. “As one of the few scaled-up and de-risked biomanufacturing assets in the country, Solugen’s Bioforge platform is helping bolster domestic capabilities and supply chains that are critical in ensuring the U.S. reaches its ambitious climate targets.”

Computationally engineered enzymes

Leveraging a combination of computationally engineered enzymes and metal catalysts, Solugen’s Bioforge converts plant-derived substances into essential materials that have traditionally been made from fossil fuels,” continued Chakrabarti. “The high efficiency and scalability of Solugen’s process can offer a significant reduction in carbon footprint compared with conventional ingredients.”

“Sustainability is one of the enduring global trends powering ADM’s growth and underpinning the strategic evolution of our Carbohydrate Solutions business,” added Chris Cuddy, president of ADM’s Carbohydrate Solutions business. “ADM is one of the largest dextrose producers in the world, and this strategic partnership will allow us to further diversify our product stream as we continue to support plant-based solutions spanning sustainable packaging, pharma, plant health, construction, fermentation, and home and personal care.”

Solugen plans to begin offsite construction this year and on-site construction in early 2024. The initial phase, which is scheduled to start up in the first half of 2025, is expected to create at least 40 permanent jobs and another 100 temporary construction jobs during commissioning.

“The initial phase of the project will significantly increase Solugen’s manufacturing capacity, which is critical for commercializing our existing line of molecules and kicks off plans for a multi-phase large-scale U.S. Bioforge buildout,” noted Sean Hunt, co-founder and CTO of Solugen. “The increase in capacity will also free up our Houston operation for research and development efforts into additional molecules and market applications.”

Previous articleAdvancing Understanding of Neurodegenerative Diseases Using Computational Methods
Next articleAbivax Advances Ulcerative Colitis Candidate with U.S. IPO